Charles Schwab’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-120,880
Closed -$738K 3622
2021
Q3
$738K Sell
120,880
-195,445
-62% -$1.19M ﹤0.01% 2993
2021
Q2
$2.6M Buy
316,325
+14,470
+5% +$119K ﹤0.01% 2622
2021
Q1
$2.7M Buy
301,855
+5,709
+2% +$51.1K ﹤0.01% 2570
2020
Q4
$3.42M Buy
296,146
+4,665
+2% +$53.8K ﹤0.01% 2401
2020
Q3
$3.04M Buy
291,481
+25,102
+9% +$261K ﹤0.01% 2321
2020
Q2
$3.5M Buy
266,379
+56,807
+27% +$747K ﹤0.01% 2195
2020
Q1
$1.65M Buy
209,572
+3,616
+2% +$28.5K ﹤0.01% 2334
2019
Q4
$4.26M Buy
205,956
+5,019
+2% +$104K ﹤0.01% 2097
2019
Q3
$2.75M Buy
200,937
+6,135
+3% +$84.1K ﹤0.01% 2266
2019
Q2
$2.4M Buy
194,802
+6,906
+4% +$85K ﹤0.01% 2308
2019
Q1
$2.35M Buy
187,896
+5,489
+3% +$68.5K ﹤0.01% 2308
2018
Q4
$2.07M Sell
182,407
-1,362
-0.7% -$15.4K ﹤0.01% 2323
2018
Q3
$3.44M Buy
183,769
+4,111
+2% +$76.9K ﹤0.01% 2237
2018
Q2
$4.65M Buy
179,658
+5,257
+3% +$136K ﹤0.01% 2040
2018
Q1
$3.91M Buy
174,401
+9,179
+6% +$206K ﹤0.01% 2064
2017
Q4
$4.14M Buy
165,222
+57,672
+54% +$1.44M ﹤0.01% 2020
2017
Q3
$2.6M Buy
107,550
+6,336
+6% +$153K ﹤0.01% 2193
2017
Q2
$2.05M Buy
101,214
+513
+0.5% +$10.4K ﹤0.01% 2214
2017
Q1
$2.71M Buy
100,701
+4,617
+5% +$124K ﹤0.01% 2079
2016
Q4
$1.83M Buy
96,084
+23,258
+32% +$442K ﹤0.01% 2214
2016
Q3
$1.42M Buy
72,826
+43,883
+152% +$858K ﹤0.01% 2287
2016
Q2
$434K Buy
28,943
+9,000
+45% +$135K ﹤0.01% 2638
2016
Q1
$184K Hold
19,943
﹤0.01% 2914
2015
Q4
$385K Hold
19,943
﹤0.01% 2759
2015
Q3
$297K Hold
19,943
﹤0.01% 2831
2015
Q2
$437K Buy
+19,943
New +$437K ﹤0.01% 2720